Corona Remedies Q2 FY27 earnings call scheduled for November 2, 2026

Board & Shareholder Meetings View source PDF Explain this filing

CORONA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹2042.00

prior close

₹2017.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.3% vs market

Pharmaceuticals peers, median of 173sector+0.1%-1.7% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.1

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.7-2.3+0.1-1.7

Next day

-1.2-1.0-0.2-1.2+0.0

-0.6-3.6+3.0-3.0+2.4

+0.0-4.5+4.5-3.9+3.9

+0.4-6.8+7.2-5.1+5.5

-0.1-6.4+6.3-3.9+3.9

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Corona Remedies will hold its Q2 FY27 earnings conference call on November 2, 2026 at 11:30 am IST to discuss financial results for the second quarter and half year ended September 30, 2026. The call is moderated by Umesh Laddha from Ambit Capital and will feature MD and CEO Nirav Mehta, Joint MD Ankur Mehta, and CFO Bhavin Bhagat. Dial-in numbers are provided for domestic and international participants.

Likely market impact

Routine disclosure; investors and analysts can join the call to hear Q2 performance directly from company leadership.